Marijuana and Kidney Function: Current Evidence and Clinical Caution

Research on cannabis and renal outcomes is limited and observational.

Key Findings

  • eGFR/creatinine: Some cross-sectional studies associate heavy chronic use with slightly lower eGFR/higher creatinine; others find no link.
  • CKD incidence: No consistent causal evidence; confounding by tobacco, alcohol, hypertension.
  • Marijuana-associated glomerulonephritis (MAGN): Rare case reports (crescentic GN, membranous); biopsy shows immune complexes; causality unproven.
  • Cannabinoid receptors (CB1/CB2) present in kidney; animal data suggest roles in sodium handling, fibrosis—human relevance unclear.

Clinical Guidance

  • Patients with CKD or transplant: Discuss with nephrologist; avoid smoking (combustion toxins).
  • Vaporization/edibles reduce pulmonary toxins but not renal uncertainty.
  • Monitor renal function if using regularly.

More longitudinal, controlled studies needed.

Kidney Disease - Related Articles